Search Results - "Vrech, C"

Therapeutic outcome 3 years after switching of immunomodulatory therapies in patients with relapsing-remitting multiple sclerosis in Argentina by Carrá, A., Onaha, P., Luetic, G., Burgos, M., Crespo, E., Deri, N., Halfon, M., Jaacks, G., López, A., Sinay, V., Vrech, C.

“…Switching treatment may be beneficial in patients with relapsing–remitting multiple sclerosis (RRMS) who respond inadequately to first‐line immunomodulatory…”
Get full text

The Sustained Disease Activity Free Status as a Measure of Therapeutic Response & the Long Term Impact of Immunomodulatory Treatment (PD5.001) by Carra, A., Rojas, G., Vrech, C., Lindembaum, S.

“…Abstract only…”
Get full text

Early Clinical Predictors of Sustained Disease-Activity-Free Status in Patients with Relapsing-Remitting Multiple Sclerosis Treated with Glatiramer Acetate and Interferon Beta (PD5.008) by Rojas, G., Vrech, C., Leguizamon, F., Lindembaum, S., Carra, A.

“…Abstract only…”
Get full text

Argentinean consensus guidelines on the identification and clinical care of secondary progressive multiple sclerosis by Cristiano, E, Patrucco, L, Ysrraelit, M C, Alonso, R, Balbuena, M E, Ballario, C, Barboza, A G, Bestoso, S, Burgos, M, Cáceres, F J, Carrá, A, Carnero-Contentti, E, Deri, N, Fernández-Liguori, N, Garcea, O, Hryb, J P, Jacobo, M, Kohler, E, Luetic, G G, Mainella, C, Menichini, M L, Míguez, J, Nofal, P G, Piedrabuena, R, Rugilo, C, Saladino, M L, Silva, B A, Silva, E, Sinay, V, Tavolini, D, Tkachuk, V A, Villa, A, Vrech, C, Rojas, J I

“…The identification, diagnosis, follow-up, and treatment of patients with secondary progressive multiple sclerosis (SPMS) show significant differences between…”
Get full text

Immunogenicity of an interferon-beta1a product by Kauffman, M A, Sterin-Prync, A, Papouchado, M, González, E, Vidal, A J, Grossberg, S E, Chuppa, S, Odoriz, B, Vrech, C, Diez, R A, Ferro, H H

“…In order to determine whether Blastoferon®, a biosimilar interferon (IFN)- beta 1a formulation, shares epitopes with other known IFN-beta products, a series of…”
Get more information